Novartis Ophthalmics
  Novartis Pharma US

 
CHANGE TEXT SIZE  Decrease Font Size Increase Font Size
Helpful Hints
Help your patients understand how their eyes work, how to care for their eyes, their children's eyes, and what tests they may receive during an eye exam.
Find Out How >

Advancing Excellence in Ophthalmology

Age-Related Macular Degeneration (AMD)



Age-related macular degeneration (AMD) is the most common cause of legal blindness among people over the age of 50 in the Western world. It affects the macula, the central part of the retina. As the photoreceptors begin to deteriorate, so does the central vision needed for everyday activities such as reading or driving. Peripheral vision is usually unaffected.

Approximately 25 to 30 million people have some form of AMD, and that number is expected to triple over the next 25 years. An estimated 6 million Americans have vision loss from AMD, and possibly another 13 to 15 million Americans have the early symptoms of the disease.

Research has yet to identify the causes of AMD. As the name suggests, the biggest risk factor is age—the disease affects almost 30% of people over age 75. The disease is more prevalent in women, Caucasians, smokers, people who are obese, and those who have a family history.

Possible preventive strategies are being investigated but have yet to be fully elucidated. Nutrition and the role of vitamins, minerals and antioxidants in the prevention of macular degeneration received considerable attention as a result of the Age Related Eye Disease Study (AREDS). In addition, the impact of other nutritional supplements, such as lutein and zeaxanthin, on eye health is currently being studied.

Back to Top


Types of Macular Degeneration
Diagnosis of Macular Degeneration
Amsler Grid
Treatment of Macular Degeneration
PRODUCTS
Find information on a specific eye care product
Read More >



Home  |  Professional Main Page  |  About Ophthalmics  |  Products
Eye Diseases & Disorders  |  Patient Education Library
Patient Assistance Program  |  Press Releases

Contact Us  |  Site Guide  |  Site Map

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2007
Novartis Pharmaceuticals Corporation. All rights reserved.